Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.

Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K.

Clin Sci (Lond). 2019 Feb 22;133(4):583-595. doi: 10.1042/CS20180980. Print 2019 Feb 28.

PMID:
30777884
2.

HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development.

Yamawaki S, Naitoh M, Kubota H, Aya R, Katayama Y, Ishiko T, Tamura T, Yoshikawa K, Enoshiri T, Ikeda M, Suzuki S.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1275. doi: 10.3390/ijms19051275.

3.

β-Adrenergic Receptor Blockers Reduce the Occurrence of Keloids and Hypertrophic Scars after Cardiac Device Implantation: A Single-Institution Case-Control Study.

Enoshiri T, Naitoh M, Yamawaki S, Kawaguchi A, Aya R, Noda K, Katayama Y, Doi T, Kawaji T, Suzuki S.

Plast Reconstr Surg. 2017 May;139(5):1248-1256. doi: 10.1097/PRS.0000000000003239.

PMID:
28092339
4.

Regeneration of elastic fibers by three-dimensional culture on a collagen scaffold and the addition of latent TGF-β binding protein 4 to improve elastic matrix deposition.

Aya R, Ishiko T, Noda K, Yamawaki S, Sakamoto Y, Tomihata K, Katayama Y, Yoshikawa K, Kubota H, Nakamura T, Naitoh M, Suzuki S.

Biomaterials. 2015 Dec;72:29-37. doi: 10.1016/j.biomaterials.2015.08.036. Epub 2015 Aug 20.

5.

The Shear Wave Velocity on Elastography Correlates with the Clinical Symptoms and Histopathological Features of Keloids.

Aya R, Yamawaki S, Yoshikawa K, Katayama Y, Enoshiri T, Naitoh M, Suzuki S.

Plast Reconstr Surg Glob Open. 2015 Aug 10;3(7):e464. doi: 10.1097/GOX.0000000000000445. eCollection 2015 Jul.

6.

Severe Acute Radiodermatitis in a Keloid Patient with Takayasu's Arteritis.

Katayama Y, Yamawaki S, Yoshimura M, Aya R, Enoshiri T, Yoshikawa K, Naitoh M, Suzuki S.

Plast Reconstr Surg Glob Open. 2015 Jan 8;2(12):e270. doi: 10.1097/GOX.0000000000000235. eCollection 2014 Dec.

7.

A toe keloid after syndactyly release treated with surgical excision and intralesional steroid injection.

Yamawaki S, Naitoh M, Ishiko T, Aya R, Katayama Y, Suzuki S.

Plast Reconstr Surg Glob Open. 2014 Aug 7;2(7):e186. doi: 10.1097/GOX.0000000000000152. eCollection 2014 Jul.

8.

Ultrasound elastography to evaluate keloids.

Aya R, Yamawaki S, Muneuchi G, Naitoh M, Suzuki S.

Plast Reconstr Surg Glob Open. 2014 Mar 6;2(2):e106. doi: 10.1097/GOX.0000000000000048. eCollection 2014 Feb. No abstract available.

9.

Treatment for infection of artificial dura mater using free fascia lata.

Nakano T, Yoshikawa K, Kunieda T, Arakawa Y, Kikuchi T, Yamawaki S, Naitoh M, Kawai K, Suzuki S.

J Craniofac Surg. 2014 Jul;25(4):1252-5. doi: 10.1097/SCS.0000000000000929.

PMID:
25006907
10.

Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".

Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H.

Sci Transl Med. 2013 Jun 5;5(188):188lr2. doi: 10.1126/scitranslmed.3005697.

11.

Chondroitinase injection improves keloid pathology by reorganizing the extracellular matrix with regenerated elastic fibers.

Ishiko T, Naitoh M, Kubota H, Yamawaki S, Ikeda M, Yoshikawa K, Fujita H, Yamaguchi H, Kurahashi Y, Suzuki S.

J Dermatol. 2013 May;40(5):380-3. doi: 10.1111/1346-8138.12116. Epub 2013 Mar 4.

PMID:
23451938
12.

Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H.

Cell Stem Cell. 2013 Apr 4;12(4):487-96. doi: 10.1016/j.stem.2013.01.009. Epub 2013 Feb 21.

13.

Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5.

Noda K, Dabovic B, Takagi K, Inoue T, Horiguchi M, Hirai M, Fujikawa Y, Akama TO, Kusumoto K, Zilberberg L, Sakai LY, Koli K, Naitoh M, von Melchner H, Suzuki S, Rifkin DB, Nakamura T.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2852-7. doi: 10.1073/pnas.1215779110. Epub 2013 Feb 4.

14.

Multipotent stem cells are effectively collected from adult human cheek skin.

Yoshikawa K, Naitoh M, Kubota H, Ishiko T, Aya R, Yamawaki S, Suzuki S.

Biochem Biophys Res Commun. 2013 Feb 1;431(1):104-10. doi: 10.1016/j.bbrc.2012.12.069. Epub 2012 Dec 22.

PMID:
23268344
15.

An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development.

Yagi Y, Muroga E, Naitoh M, Isogai Z, Matsui S, Ikehara S, Suzuki S, Miyachi Y, Utani A.

J Invest Dermatol. 2013 Feb;133(2):386-93. doi: 10.1038/jid.2012.314. Epub 2012 Sep 6.

16.

Drug screening for ALS using patient-specific induced pluripotent stem cells.

Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H.

Sci Transl Med. 2012 Aug 1;4(145):145ra104. doi: 10.1126/scitranslmed.3004052.

17.

Keloids can be forced into remission with surgical excision and radiation, followed by adjuvant therapy.

Yamawaki S, Naitoh M, Ishiko T, Muneuchi G, Suzuki S.

Ann Plast Surg. 2011 Oct;67(4):402-6. doi: 10.1097/SAP.0b013e31820d684d.

PMID:
21407049
18.

Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.

Yasue S, Masuzaki H, Okada S, Ishii T, Kozuka C, Tanaka T, Fujikura J, Ebihara K, Hosoda K, Katsurada A, Ohashi N, Urushihara M, Kobori H, Morimoto N, Kawazoe T, Naitoh M, Okada M, Sakaue H, Suzuki S, Nakao K.

Am J Hypertens. 2010 Apr;23(4):425-31. doi: 10.1038/ajh.2009.263. Epub 2010 Jan 7.

19.

Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid.

Ikeda M, Naitoh M, Kubota H, Ishiko T, Yoshikawa K, Yamawaki S, Kurokawa M, Utani A, Nakamura T, Nagata K, Suzuki S.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1221-8. doi: 10.1016/j.bbrc.2009.10.125. Epub 2009 Oct 29.

PMID:
19879246
20.

[Clinical regenerative medicine: the skin].

Suzuki S, Morimoto N, Naitoh M.

Nihon Rinsho. 2008 May;66(5):961-5. Review. Japanese.

PMID:
18464517

Supplemental Content

Loading ...
Support Center